Jafron Biomedical Co Ltd (300529) - Total Liabilities

Latest as of March 2026: CN¥1.82 Billion CNY ≈ $266.57 Million USD

Based on the latest financial reports, Jafron Biomedical Co Ltd (300529) has total liabilities worth CN¥1.82 Billion CNY (≈ $266.57 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Jafron Biomedical Co Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Jafron Biomedical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 300529 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Jafron Biomedical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jafron Biomedical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Electric Wind Power Group Co. Ltd. A SHG:688660	China	CN¥29.88 Billion
Guodian Nanjing Automation Co Ltd SHG:600268	China	CN¥6.88 Billion
Telecom Argentina S.A F:TEO	Germany	€9.64 Trillion
Xi An Triangle Defens Co Ltd SHE:300775	China	CN¥2.67 Billion
Costamare Inc NYSE:CMRE	USA	$1.70 Billion
Lianhe Chemical Technology Co Ltd SHE:002250	China	CN¥6.70 Billion
Wuxi Dk Electronic Materials Co Ltd SHE:300842	China	CN¥10.75 Billion
Farglory Land Development Co Ltd TW:5522	Taiwan	NT$64.70 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Jafron Biomedical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300529 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.71	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jafron Biomedical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jafron Biomedical Co Ltd (2011–2025)

The table below shows the annual total liabilities of Jafron Biomedical Co Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.94 Billion ≈ $283.54 Million	-5.43%
2024-12-31	CN¥2.05 Billion ≈ $299.80 Million	-14.29%
2023-12-31	CN¥2.39 Billion ≈ $349.79 Million	+31.13%
2022-12-31	CN¥1.82 Billion ≈ $266.76 Million	+27.80%
2021-12-31	CN¥1.43 Billion ≈ $208.74 Million	+272.38%
2020-12-31	CN¥383.06 Million ≈ $56.05 Million	+18.18%
2019-12-31	CN¥324.13 Million ≈ $47.43 Million	-1.79%
2018-12-31	CN¥330.04 Million ≈ $48.30 Million	+6.16%
2017-12-31	CN¥310.90 Million ≈ $45.49 Million	+168.46%
2016-12-31	CN¥115.81 Million ≈ $16.95 Million	-7.06%
2015-12-31	CN¥124.61 Million ≈ $18.23 Million	+43.91%
2014-12-31	CN¥86.59 Million ≈ $12.67 Million	+6.11%
2013-12-31	CN¥81.60 Million ≈ $11.94 Million	+60.83%
2012-12-31	CN¥50.74 Million ≈ $7.42 Million	+65.41%
2011-12-31	CN¥30.68 Million ≈ $4.49 Million	--

About Jafron Biomedical Co Ltd

SHE:300529 China Medical Devices

Market Cap

$1.83 Billion

CN¥12.54 Billion CNY

Market Cap Rank

#6604 Global

#1444 in China

Share Price

CN¥15.70

Change (1 day)

-0.63%

52-Week Range

CN¥15.70 - CN¥24.54

All Time High

CN¥96.12